Self-Healing Conductive Injectable Hydrogels with Antibacterial Activity as Cell Delivery Carrier for Cardiac Cell Therapy

2016 ◽  
Vol 8 (27) ◽  
pp. 17138-17150 ◽  
Author(s):  
Ruonan Dong ◽  
Xin Zhao ◽  
Baolin Guo ◽  
Peter X. Ma
Cytotherapy ◽  
2012 ◽  
Vol 14 (3) ◽  
pp. 260-266 ◽  
Author(s):  
Kai Hong Wu ◽  
Xu Ming Mo ◽  
Zhong Chao Han ◽  
Bin Zhou

Gels ◽  
2021 ◽  
Vol 7 (1) ◽  
pp. 7
Author(s):  
Cecilie Hoeeg ◽  
Alireza Dolatshahi-Pirouz ◽  
Bjarke Follin

Cell therapy has the potential to regenerate cardiac tissue and treat a variety of cardiac diseases which are currently without effective treatment. This novel approach to treatment has demonstrated clinical efficiency, despite low retention of the cell products in the heart. It has been shown that improving retention often leads to improved functional outcome. A feasible method of improving cell graft retention is administration of injectable hydrogels. Over the last decade, a variety of injectable hydrogels have been investigated preclinically for their potential to improve the effects of cardiac cell therapy. These hydrogels are created with different polymers, properties, and additional functional motifs and differ in their approaches for encapsulating different cell types. Only one combinational therapy has been tested in a clinical randomized controlled trial. In this review, the latest research on the potential of injectable hydrogels for delivery of cell therapy is discussed, together with potential roadblocks for clinical translation and recommendations for future explorations to facilitate future translation.


2010 ◽  
Vol 58 (S 01) ◽  
Author(s):  
B Nasseri ◽  
M Kukucka ◽  
SJ Kim ◽  
YH Choi ◽  
KS Kang ◽  
...  

2012 ◽  
Vol 60 (S 01) ◽  
Author(s):  
R Roy ◽  
M Kukucka ◽  
D Messroghli ◽  
A Brodarac ◽  
M Becher ◽  
...  

2015 ◽  
Vol 116 (8) ◽  
pp. 1291-1292 ◽  
Author(s):  
Birgit Assmus ◽  
Stefanie Dimmeler ◽  
Andreas M. Zeiher

2012 ◽  
Vol 2012 ◽  
pp. 1-11 ◽  
Author(s):  
Duc Thang Vu ◽  
Theo Kofidis

Myocardial infarction is the leading cause of death in developed countries. Cardiac cell therapy has been introduced to clinical trials for more than ten years but its results are still controversial. Tissue engineering has addressed some limitations of cell therapy and appears to be a promising solution for cardiac regeneration. In this review, we would like to summarize the current understanding about the therapeutic effect of cell therapy and tissue engineering under purview of functional and structural aspects, highlighting actual roles of each therapy towards clinical application.


Sign in / Sign up

Export Citation Format

Share Document